PATENT CLAIM ANALYSIS

Application Number: 15885267
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure relates to a vaccine composition, wherein the vaccine composition comprises an immune amount of fowl adenovirus Fiber-2 protein or an immune amount of a live vector recombined with gene of the fowl adenovirus Fiber-2 protein, and a pharmaceutically acceptable carrier. The vaccine composition can provide effective immune protection against different serotypes of adenoviruses and provide a protection rate of 100% at low levels of immunogenic components, showing good immunological efficacy.

Claim (Index 12):
The vaccine composition according to  claim 11 , wherein the antigens of Newcastle disease virus are inactivated antigens of N7a strain, the antigens of avian influenza virus are inactivated antigens of SZ strain, the antigens of avian infectious bronchitis virus are inactivated antigens of M41 strain, the antigens of infectious bursal disease virus are inactivated antigens of VP2 protein and the antigens of egg drop syndrome virus are inactivated antigens of AV-127 strain.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.54902
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10429735', '14020024', '14682798', '10377718', '14747419']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7689617900470703
- 35 USC 102 Novelty (BERT): 0.5188446232163141
- Combined Prediction Score: 0.7439500733639948
- Mean Citation Score: 292.112548
- Max Citation Score: 312.93018
- Similarity Product: 224.20516165183068

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test